Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Premier Anti-Aging Co., Ltd. ( (JP:4934) ).
Premier Anti-Aging reported a 13.9% year-on-year decline in net sales to ¥7.34 billion for the first half of the fiscal year ending July 31, 2026, with operating profit down 36.0% to ¥626 million and profit attributable to owners of parent falling 23.4% to ¥445 million. Despite profit pressure, the company’s equity ratio improved to 67.0% and shareholders’ equity increased, indicating a relatively solid balance sheet amid weaker earnings.
The company maintained its full-year forecast, projecting modest net sales growth of 2.1% to ¥16.5 billion but a sharp drop in operating profit of 51.4%, signaling expectations of continued margin compression. It also kept its no-dividend policy for the current fiscal year, suggesting a focus on preserving capital and financial flexibility, which may temper income expectations for shareholders while supporting longer-term operational resilience.
The most recent analyst rating on (JP:4934) stock is a Hold with a Yen854.00 price target. To see the full list of analyst forecasts on Premier Anti-Aging Co., Ltd. stock, see the JP:4934 Stock Forecast page.
More about Premier Anti-Aging Co., Ltd.
Premier Anti-Aging Co., Ltd. is a Tokyo Stock Exchange-listed company in the beauty and personal care sector, focused on anti-aging products. The company targets consumers seeking premium skincare and related solutions, positioning itself in a niche of high-value, health and beauty offerings with an emphasis on sustained brand and market development.
Average Trading Volume: 25,677
Technical Sentiment Signal: Sell
Current Market Cap: Yen6.49B
For a thorough assessment of 4934 stock, go to TipRanks’ Stock Analysis page.